Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

"Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"

Phase 3

Completed

Conditions: Ocular Redness

Interventions: Drug: Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
Drug: Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation

First Posted Date: 2022-05-04

Last Posted Date: 2024-08-26

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 380

Registration Number: NCT05360784

Locations: 🇺🇸
Bausch Site 04, Colorado Springs, Colorado, United States
🇺🇸
Bausch Site 06, Clinton, Utah, United States
🇺🇸
Bausch Site 03, Shelby, North Carolina, United States

and more 3 locations

1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia

Not Applicable

Completed

Conditions: Presbyopia

Interventions: Device: samfilcon A for Presbyopia
Device: kalifilcon A Daily Disposable Multifocal

First Posted Date: 2022-04-13

Last Posted Date: 2022-04-13

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT05325931

Locations: 🇺🇸
Bausch site 1, Rochester, New York, United States

1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism

Not Applicable

Completed

Conditions: Myopia
Astigmatism

Interventions: Device: Ultra for Astigmatism Contact Lenses
Device: kalifilcon A Daily Disposable Toric

First Posted Date: 2022-04-11

Last Posted Date: 2022-11-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 28

Registration Number: NCT05320042

Locations: 🇺🇸
Bausch site 1, Rochester, New York, United States

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Not Applicable

Recruiting

Conditions: Hyperopia

Interventions: Device: TENEO 317 Model 2 excimer laser

First Posted Date: 2022-03-03

Last Posted Date: 2024-08-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 140

Registration Number: NCT05264623

Locations: 🇺🇸
Site 113, Newport Beach, California, United States
🇺🇸
Site 111, Fort Myers, Florida, United States
🇺🇸
Bausch Site 104, Saint Louis Park, Minnesota, United States

and more 9 locations

Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses

Not Applicable

Completed

Conditions: Contact Lens Wearer

Interventions: Device: All participants received Biotrue ONEday lenses with and without an alternate packaging solution (EPG03)

First Posted Date: 2021-11-22

Last Posted Date: 2024-04-16

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 33

Registration Number: NCT05129488

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses

Not Applicable

Completed

Conditions: Astigmatism

Interventions: Device: kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
Device: Commercially available Ultra for Astigmatism Contact Lenses

First Posted Date: 2021-11-22

Last Posted Date: 2022-03-31

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT05129124

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Not Applicable

Completed

Conditions: Contact Lens Wearer

Interventions: Device: kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

First Posted Date: 2021-11-22

Last Posted Date: 2021-11-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 180

Registration Number: NCT05129072

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Not Applicable

Completed

Conditions: Contact Lens Wearer

Interventions: Device: samfilcon A Lenses with EPG01 Packaging Solution
Device: B+L Ultra Lenses

First Posted Date: 2021-11-19

Last Posted Date: 2021-11-19

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT05126953

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses

Completed

Conditions: Corneal Astigmatism

Interventions: Device: enVista non-Toric (spherical)
Device: enVista Toric

First Posted Date: 2021-10-13

Last Posted Date: 2024-03-27

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 302

Registration Number: NCT05075746

Locations: 🇨🇦
Bausch Site 03, Langley, British Columbia, Canada
🇨🇦
Bausch Site 02, Toronto, Ontario, Canada
🇨🇦
Bausch Site 01, Calgary, Alberta, Canada

Product Performance of a New Silicone Hydrogel Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: kalifilcon A
Device: delefilcon A
Device: senofilcon A

First Posted Date: 2021-05-26

Last Posted Date: 2021-07-08

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 805

Registration Number: NCT04901897

Locations: 🇺🇸
Bausch Site 431, Scottsdale, Arizona, United States
🇺🇸
Bausch Site 406, Azusa, California, United States
🇺🇸
Bausch Site 430, Los Angeles, California, United States

and more 32 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy